FDA
-
Trends
Mammoth Biosciences’s CRISPR-based COVID-19 test receives NIH fundings through RADx program
CRISPR tech startup Mammoth Biosciences is among the companies that revealed backing from the National Institutes of Health (NIH) Rapid…
Read More »